Autoimmune disease comorbidities in patients with atopic dermatitis: A nationwide case-control study in Taiwan

Pediatric Allergy and Immunology

Volumn 25, Issue 6, 2014, Pages 586-592

  Wu, Lung Chi ^a,b,c,d,e   Hwang, Chian Yaw ^d,f,g   Chung, Pei I ^a,d   Hua, Tuan Chun ^a,d   Chen, Yen Da ^a,d   Chu, Szu Yin ^a,d   Lee, Din Dar ^a,d   Chang, Yun Ting ^a,d   Wang, Wen Jen ^a,c,d   Liu, Han Nan ^a,c,d   Chen, Chih Chiang ^a,d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^g Dr Jen Shang Huang's Dermatology Clinic   (Taiwan)

Author keywords

Atopic dermatitis; Autoimmune disease; Nationwide; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; FEMALE; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; TAIWAN; YOUNG ADULT; ADOLESCENT; AGE; CHILD; DERMATITIS, ATOPIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; POPULATION GROUP; RISK FACTOR;

ADOLESCENT; ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CHILD; COMORBIDITY; DERMATITIS, ATOPIC; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POPULATION GROUPS; RISK FACTORS; SEX FACTORS; TAIWAN; YOUNG ADULT;

EID: 84922829679     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12274     Document Type: Article

References (57)

1. Hwang CY, Chen YJ, Lin MW, et al. Prevalence of atopic dermatitis, allergic rhinitis and asthma in Taiwan: a national study 2000 to 2007. Acta Derm Venereol 2010: 90: 589-94.
2. Illi S, von Mutius E, Lau S, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004: 113: 925-31.
3. Bieber T. Atopic dermatitis. N Engl J Med 2008: 358: 1483-94.
4. Cork MJ, Danby SG, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009: 129: 1892-908.
5. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006: 38: 441-6.
6. Grewe M, Walther S, Gyufko K, Czech W, Schopf E, Krutmann J. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 1995: 105: 407-10.
7. Taha RA, Leung DY, Ghaffar O, Boguniewicz M, Hamid Q. In vivo expression of cytokine receptor mRNA in atopic dermatitis. J Allergy Clin Immunol 1998: 102: 245-50.
8. Lafaille JJ. The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev 1998: 9: 139-51.
9. Funauchi M, Ikoma S, Enomoto H, Horiuchi A. Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus. Scand J Rheumatol 1998: 27: 219-24.
10. Lo WC, Arsenescu RI, Friedman A. Mathematical Model of the Roles of T Cells in Inflammatory Bowel Disease. Bull Math Biol 2013: 75: 1417-33.
11. Rabin RL, Levinson AI. The nexus between atopic disease and autoimmunity: a review of the epidemiological and mechanistic literature. Clin Exp Immunol 2008: 153: 19-30.
12. Feizy V, Ghobadi A. Atopic dermatitis and systemic autoimmune diseases: a descriptive cross sectional study. Dermatol Online J 2006: 12: 3.
13. Executive Yuan RoC. The republic of China yearbook 2012. http://www.ey.gov.tw/en/cp.aspx?n=CBDA2319F19402AE (Last accessed 7 February, 2012).
14. Chu SY, Chen YJ, Tseng WC, et al. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol 2011: 65: 949-56.
15. Hwang CY, Chen YJ, Lin MW, et al. Cancer risk in patients with allergic rhinitis, asthma and atopic dermatitis: a nationwide cohort study in Taiwan. Int J Cancer 2012: 130: 1160-7.
16. Hwang CY, Hwang YY, Chen YJ, et al. Atopic Diathesis in Patients with Kawasaki Disease. J Pediatr 2013: 163: 811-5.
17. Chu SY, Chen YJ, Tseng WC, et al. Psychiatric comorbidities in patients with alopecia areata in Taiwan: a case-control study. Br J Dermatol 2012: 166: 525-31.
18. Chang Y-J, Yeh M-L, Li Y-C, Hsu C-Y, et al. Potential drug interactions in dermatologic outpatient prescriptions-experience from nationwide population-based study in Taiwan. Dermatologica Sinica 2011: 29: 81-5.
19. Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis-a prospective follow-up to 7 years of age. Allergy 2000: 55: 240-5.
20. Warner JO, Child ESGETotA. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. J Allergy Clin Immunol 2001: 108: 929-37.
21. Kjellman NI, Nilsson L. From food allergy and atopic dermatitis to respiratory allergy. Pediatr Allergy Immunol 1998: 9: 13-7.
22. Hilliquin P, Allanore Y, Coste J, Renoux M, Kahan A, Menkes CJ. Reduced incidence and prevalence of atopy in rheumatoid arthritis. Results of a Case-Control Study. Rheumatology (Oxford) 2000: 39: 1020-6.
23. Rudwaleit M, Andermann B, Alten R, et al. Atopic disorders in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 2002: 61: 968-74.
24. Decreased prevalence of atopic diseases in children with diabetes. The EURODIAB Substudy 2 Study Group. J Pediatr 2000: 137: 470-4.
25. Olesen AB, Juul S, Birkebaek N, Thestrup-Pedersen K. Association between atopic dermatitis and insulin-dependent diabetes mellitus: a case-control study. Lancet 2001: 357: 1749-52.
26. Klinman DM, Steinberg AD. Inquiry into murine and human lupus. Immunol Rev 1995: 144: 157-93.
27. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985: 37: 269-390.
28. Ogawa N, Itoh M, Goto Y. Abnormal production of B cell growth factor in patients with systemic lupus erythematosus. Clin Exp Immunol 1992: 89: 26-31.
29. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 1991: 147: 117-23.
30. Llorente L, Richaud-Patin Y, Wijdenes J, et al. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 1993: 4: 421-7.
31. Takahashi S, Fossati L, Iwamoto M, et al. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 1996: 97: 1597-604.
32. al-Janadi M, al-Balla S, al-Dalaan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993: 13: 58-67.
33. Peng SL, Moslehi J, Craft J. Roles of interferon-gamma and interleukin-4 in murine lupus. J Clin Invest 1997: 99: 1936-46.
34. Akahoshi M, Nakashima H, Tanaka Y, et al. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 1999: 42: 1644-8.
35. Segal R, Bermas BL, Dayan M, Kalush F, Shearer GM, Mozes E. Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease. J Immunol 1997: 158: 3009-16.
36. Higashi N, Kawana S. Atopic eczema complicated by systemic lupus erythematosus. Eur J Dermatol 2005: 15: 500-2.
37. Chavele KM, Ehrenstein MR. Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis. FEBS Lett 2011: 585: 3603-10.
38. Verhagen J, Akdis M, Traidl-Hoffmann C, et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 2006: 117: 176-83.
39. Valencia X, Yarboro C, Illei G, Lipsky PE. Deficient CD4 + CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007: 178: 2579-88.
40. Lyssuk EY, Torgashina AV, Soloviev SK, Nassonov EL, Bykovskaia SN. Reduced number and function of CD4 + CD25highFoxP3 + regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol 2007: 601: 113-9.
41. Mellor-Pita S, Citores MJ, Castejon R, et al. Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann Rheum Dis 2006: 65: 553-4.
42. Venigalla RK, Tretter T, Krienke S, et al. Reduced CD4+, CD25- T cell sensitivity to the suppressive function of CD4+, CD25high, CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum 2008: 58: 2120-30.
43. Barath S, Aleksza M, Tarr T, Sipka S, Szegedi G, Kiss E. Measurement of natural (CD4 + CD25high) and inducible (CD4 + IL-10 + ) regulatory T cells in patients with systemic lupus erythematosus. Lupus 2007: 16: 489-96.
44. Simon D, Aeberhard C, Erdemoglu Y, Simon HU. Th17 cells and tissue remodeling in atopic and contact dermatitis. Allergy 2014: 69: 125-31.
45. Pennino D, Eyerich K, Scarponi C, et al. IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes. J Immunol 2010: 184: 4880-8.
46. Oh SH, Roh HJ, Kwon JE, et al. Expression of interleukin-17 is correlated with interferon-alpha expression in cutaneous lesions of lupus erythematosus. Clin Exp Dermatol 2011: 36: 512-20.
47. Martin JC, Baeten DL, Josien R. Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus. Clin Immunol 2014: 154: 1-12.
48. Wong CK, Lit LC, Tam LS, Li EK, Wong PT, Lam CW. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol. 2008: 127: 385-93.
49. Chen XQ, Yu YC, Deng HH, et al. Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity. J Clin Immunol 2010: 30: 221-5.
50. Zhao XF, Pan HF, Yuan H, et al. Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep 2010: 37: 81-5.
51. Tanasescu C, Balanescu E, Balanescu P, et al. IL-17 in cutaneous lupus erythematosus. Eur J Int Med 2010: 21: 202-7.
52. Buyon JP, Petri MA, Kim MY, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005: 142: 953-62.
53. Liphaus BL, Jesus AA, Silva CA, Coutinho A, Carneiro-Sampaio M. Increased IgE serum levels are unrelated to allergic and parasitic diseases in patients with juvenile systemic lupus erythematosus. Clinics (Sao Paulo) 2012: 67: 1275-80.
54. Liston A, Enders A, Siggs OM. Unravelling the association of partial T-cell immunodeficiency and immune dysregulation. Nat Rev Immunol 2008: 8: 545-58.
55. Ring GH, Lakkis FG. Breakdown of self-tolerance and the pathogenesis of autoimmunity. Semin Nephrol 1999: 19: 25-33.
56. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994: 12: 227-57.
57. Atta AM, Sousa CP, Carvalho EM, Sousa-Atta ML. Immunoglobulin E and systemic lupus erythematosus. Braz J Med Biol Res = Revista Brasileira de Pesquisas Medicas e Biologicas/Sociedade Brasileira de Biofisica [et al.]. 2004: 37: 1497-501.